-
1-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-3-[1-(methoxymethoxy)ethyl]-4-(2-phenoxyethyl)-4,5-dihydro-1H-1,2,4-triazol-5-one
-
ChemBase ID:
172995
-
Molecular Formular:
C27H36ClN5O4
-
Molecular Mass:
530.05884
-
Monoisotopic Mass:
529.24558234
-
SMILES and InChIs
SMILES:
C1N(CCN(C1)c1cc(ccc1)Cl)CCCn1nc(n(c1=O)CCOc1ccccc1)C(OCOC)C
Canonical SMILES:
COCOC(c1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl)C
InChI:
InChI=1S/C27H36ClN5O4/c1-22(37-21-35-2)26-29-33(27(34)32(26)18-19-36-25-10-4-3-5-11-25)13-7-12-30-14-16-31(17-15-30)24-9-6-8-23(28)20-24/h3-6,8-11,20,22H,7,12-19,21H2,1-2H3
InChIKey:
KGMZBWNECBSLAH-UHFFFAOYSA-N
-
Cite this record
CBID:172995 http://www.chembase.cn/molecule-172995.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
|
IUPAC name
|
|
1-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-3-[1-(methoxymethoxy)ethyl]-4-(2-phenoxyethyl)-4,5-dihydro-1H-1,2,4-triazol-5-one
|
|
|
|
|
IUPAC Traditional name
|
|
2-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-5-[1-(methoxymethoxy)ethyl]-4-(2-phenoxyethyl)-1,2,4-triazol-3-one
|
|
|
|
|
Synonyms
|
|
2-[3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl]-2,4-dihydro-5-[1-(methoxymethoxy)ethyl]-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one
|
|
Methoxymethoxy Nefazodone
|
|
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
|
Data Source
|
Data ID
|
Price
|
|
TRC
|
|
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
|
H Acceptors
|
7
|
H Donor
|
0
|
LogD (pH = 5.5)
|
2.8163545
|
LogD (pH = 7.4)
|
4.2377872
|
Log P
|
4.4102
|
Molar Refractivity
|
144.5494 cm3
|
Polarizability
|
55.779247 Å3
|
Polar Surface Area
|
70.08 Å2
|
Rotatable Bonds
|
13
|
Lipinski's Rule of Five
|
false
|
DETAILS
DETAILS
TRC
REFERENCES
REFERENCES
From Suppliers
Google Scholar
PubMed
Google Books
- • Barbhaiya, R., et al.: Eur. J. Clin. Pharmacol., 49, 221 (1995)
- • Greene, D., et al.: Clin. Pharmacokinet., 33, 260 (1995)
- • Kalgutkar, A., et al.: Drug Metab. Dispos., 33, 243 (1995)
- Searching...Please wait...
PATENTS
PATENTS
PubChem Patent
Google Patent